Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

ADVBADVB
4 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in Advanced Biomed Inc.

No. Citadel Advisors exited its ADVB (Advanced Biomed) position in Q4 2025. Its Q3 2025 13F listed 139,511 shares worth $62,515. Citadel Advisors first reported ADVB in Q1 2025 and held it in 3 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$44,740

Total Shares Change

-11,213

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$0.34
0
2025-Q3
Increased
139,511
+141.9%
$62,5150.0%$0.45
23
2025-Q2
Increased
57,668
+414.3%
$40,3680.0%$0.71
22
2025-Q1
New
11,213
-
$44,7400.0%$4.00
31

Other major holders of ADVB: XTX Topco Ltd, UBS Group AG, RENAISSANCE TECHNOLOGIES LLC, Virtu Financial LLC, HRT FINANCIAL LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used